---
title: "SL Science declines 2% in regular trading as prior weakness continues"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291565232.md"
description: "SLBT declines 2% in regular trading to $4.34, extending prior weakness after 5% premarket drop on 07/01."
datetime: "2026-07-02T15:02:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291565232.md)
  - [en](https://longbridge.com/en/news/291565232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291565232.md)
generator: "portal-rs"
---

# SL Science declines 2% in regular trading as prior weakness continues

SL Science(SLBT.US) 盘中跌**2.43%**，现报**4.342 美元**。

该公司 07/01 盘前曾下跌 5%，此次盘中急跌或为前一日弱势的延续。

### Related Stocks

- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)

## Related News & Research

- [SL Science Seeks FDA Orphan Drug Status for Gamma Delta T Cell Therapy in Glioblastoma](https://longbridge.com/en/news/292326758.md)
- [SL Science Holding files Form 3 as CEO Ching-Dong Wang reports 333,832,129 shares beneficially owned](https://longbridge.com/en/news/290244372.md)
- [SL Science FY25 net loss widens to USD 3.82 million; revenue falls 35% to USD 2.2 million](https://longbridge.com/en/news/290247592.md)
- [SL Science Holding Limited Reports Full Year 2025 Financial Results | SLBT Stock News](https://longbridge.com/en/news/290247925.md)
- [Ching-Dong Wang Discloses Investment at SL Science Holding Ltd with 59.53% Stake](https://longbridge.com/en/news/290245423.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**